Concepedia

Mark A. Sanner

MA

1

Publications

38

Citations

1

H-Index

1998

Active since

Affiliations

Pfizer (United States)(Current)

Mark A. Sanner is an author at Pfizer (United States) specializing in drug discovery, dopamine research, and pharmacotherapy.

Top concepts

Publications per year

1998–1998

1

Publications

1

Synthesis, sar and pharmacology of CP-293,019: A potent, selective dopamine D4 receptor antagonist

Mark A. Sanner, Thomas A. Chappie, A. DUNAISKIS et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 38 citations · Full text

, , +5

Rows per page

1–1 of 1